728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads
728 x 90 Leaderboard Ads

CyPass® Ushers in Exciting New Era of Glaucoma Treatment

FORT MYERS, Fla., Feb. 5, 2018 /PRNewswire/ — Individuals who need cataract surgery, who also have glaucoma and live in Southwest Florida just hit the jackpot.

Always a leader in ophthalmic treatments and technologies, Frantz EyeCare introduces the latest advancement in glaucoma care: CyPass Micro-Stent, which helps patients reduce or even eliminate the need for prescription eye drops to control their intraocular pressure (IOP).

Frantz EyeCare offers this amazing breakthrough procedure in conjunction with cataract surgery, saving patients time and money.

“The device is tiny,” said Dr. Jonathan Frantz, Founder and Medical Director of Frantz EyeCare. “You won’t feel it or know it’s there. The stent is implanted at the same time as your cataract surgery, is minimally invasive and the device works in harmony with your eye’s natural anatomy.”

The greatest news? According to research, many patients are able to reduce or eliminate their glaucoma drops due to CyPass’s ability to decrease eye pressure. 

The recent research was a two-year study called the COMPASS trial, the largest randomized, controlled trial for CyPass Micro-Stent to date with more than 500 patients. CyPass patients enjoyed superior outcomes across the board. In fact, 93 percent of respondents in the CyPass group were still medication free after two years.

What is Glaucoma?
Glaucoma affects around two million Americans. The condition damages the optic nerve, the part of the eye that carries images we see to the brain. As glaucoma worsens, cells die in the retina, reducing the optic nerve’s ability to relay visual information to the brain. In the most common form, open-angle glaucoma, peripheral vision narrows, then blank spots occur in the visual field. Symptoms of the less-common angle-closure glaucoma include blurred vision, eye pain and headache, halos around lights, nausea and vomiting.

Jonathan M. Frantz, MD, FACS and Frantz EyeCare
Dr. Frantz is named in The Guide to America’s Top Ophthalmologists. He and his team offer a broad spectrum of patient-focused care from eye exams and eyewear to bladeless laser cataract removal, treatment of eye diseases, bladeless LASIK and cosmetic surgery with office locations in Fort Myers, Cape Coral, Punta Gorda, Lehigh Acres and Naples.

The doctors at Frantz EyeCare are world-class leaders in glaucoma diagnosis, treatment and management. To schedule an evaluation today, call (239) 418-0999 or visit bettervision.net.

Contact: Natalie Waskel, Miller Public Relations
Phone #: (817) 281-3440

Cision View original content:http://www.prnewswire.com/news-releases/cypass-ushers-in-exciting-new-era-of-glaucoma-treatment-300593489.html

SOURCE Frantz EyeCare

Related Links

http://bettervision.net

About The Author

Related posts

Leave a Reply

Your email address will not be published. Required fields are marked *